Flowserve/Velan: France's Rejection of Deal Reveals Sensitive Assets Remain Off Limits, Even to Allies

Flowserve/Velan: France’s Rejection of Deal Reveals Sensitive Assets Remain Off Limits, Even to Allies

Published on Nov 02, 2023

France’s rejection of U.S.-based Flowserve’s (FLS) proposed $245 million purchase of Canadian industrial valve manufacturer Velan (TSX: VLN) last month should serve as a warning to dealmakers regarding the limits of trust between even longstanding allies, trade and national security attorneys said. As some in the national security sector had suspected, the French Ministry of […]

Merger Lobbying Picks Up as ‘MAGA Lobbyists’ Cash in on Trumpworld Connections

Merger-related lobbying ticked up slightly in the third quarter as lobbyists connected to President Donald Trump worked to boost support for pending deals involving Nexstar (NXST), Tegna (TGNA),...

Oct 22, 2025 Read Now >

Gildan/HanesBrands: Paperwork Pulled and Refiled, Giving FTC More Time to Conduct Initial Review

Gildan Activewear (GIL) pulled and refiled the HSR form for its planned acquisition of HanesBrands (HBI), according to a company spokesperson, giving the FTC 30 additional days to conduct an initial...

Oct 21, 2025 Read Now >

Saudi Role in Electronic Arts Takeover Likely to Face EU Scrutiny Under Foreign Subsidies Rules, Sources Say

The European Commission is expected to assess whether Saudi Arabia’s role in a consortium to acquire Electronic Arts (EA) for $55 billion will give the country outsized influence over the EU gaming...

Oct 21, 2025 Read Now >

Flowserve/Velan: France’s Rejection of Deal Reveals Sensitive Assets Remain Off Limits, Even to Allies

RELATED ARTICLES | Editor’s picks

Merger Lobbying Picks Up as ‘MAGA Lobbyists’ Cash in on Trumpworld Connections

Gildan/HanesBrands: Paperwork Pulled and Refiled, Giving FTC More Time to Conduct Initial Review

Saudi Role in Electronic Arts Takeover Likely to Face EU Scrutiny Under Foreign Subsidies Rules, Sources Say

FILTER BY

This article is currently locked and only available to subscribers. Request a trial to receive unlimited access to all articles.